SUMITOMO PHARMA CO LTD revenue for the last year amounted to 314.56 B JPY, the most of which — 314.56 B JPY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 510.72 B JPY. The greatest contribution to the revenue figure was made by North America — last year it brought SUMITOMO PHARMA CO LTD 159.04 B JPY, and the year before that — 328.47 B JPY.